Recent advances in Breast MRI and MRS

NMR in Biomedicine

Volumn 22, Issue 1, 2009, Pages 3-16

  Sinha, S ^a   Sinha, U ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Breast; Computerized analysis; Diffusion weighted MR; Dynamic contrast enhanced MRI; MR elastography; MR multi parametric evaluation; MRI; MRS; Perfusion MR

Indexed keywords

BREAST; COMPUTERIZED ANALYSIS; DYNAMIC CONTRAST ENHANCED MRI; MR ELASTOGRAPHY; MR MULTI-PARAMETRIC EVALUATION; MRI; MRS; PERFUSION MR;

DIAGNOSIS; DIFFUSION; FEATURE EXTRACTION; IMAGE ANALYSIS; MAGNETIC RESONANCE SPECTROSCOPY;

RECONNAISSANCE AIRCRAFT;

BREAST CANCER; CANCER MORPHOLOGY; CANCER SCREENING; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; ELASTOGRAPHY; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; INTERMETHOD COMPARISON; INVASIVE CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PAGET NIPPLE DISEASE; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; REVIEW; SPECTROSCOPY;

BREAST; BREAST NEOPLASMS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 65249155437     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1270     Document Type: Review

References (123)

1. Kacl GM, Liu P, Debatin JF, Garzoli E, Caduff RF, Krestin GP. Detection of breast cancer with conventional mammography and contrast-enhanced MR imaging. Eur Radiol 1998; 8: 194-200.
2. Heywang-Kobrunner SH, Beck R. Contrast Enhanced MRI of the Breast, 2nd edn. Springer-Verlag: Berlin, Heidelberg, New York, 1995.
3. Rotaru N, Luciani A. Magnetic resonance imaging of the breast: potential for lesion characterization. J. BUON 2004; 9: 77-82.
4. Drew PJ, Chatterjee S, Turnbull LW, Read J, Carleton PJ, Fox JN, Monson JR, Kerin MJ. Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancer. Ann Surg Oncol 1999; 6: 599-603.
5. Kelcz F, Santyr GE, Cron GO, Mongin SJ. Application of a quantitative model to differentiate benign from malignant breast lesions detected by dynamic, gadolinium-enhanced MRI. J. Magn Reson Imaging 1996; 6: 743-752.
6. Muller-Schimpfle M, Ohmenhauser K, Sand J, Stoll P. Claussen CD. Dynamic 3D-MR mammography: is there a benefit of sophisticated evaluation of enhancement curves for clinical routine?J Magn Reson Imaging 1997; 7: 236-240.
7. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, Morris E, Pisano E, Schnall M, Sener S, Smith RA, Warner E, Yaffe M, Andrews KS. Russell CA for the American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. Cancer J Clin 2007; 57: 75-89.
8. Van Goethem M, Tjalma W, Schelfout K, Verslegers I, Biltjes I, Parizel P. Magnetic resonance imaging in breast cancer. Eur J Surg Oncol 2006; 32: 901-910.
9. Bartella L, Smith CS, Dershaw DD, Liberman L. Imaging breast cancer. Radiol Clin North Am 2007; 45: 45-67.
10. Goto M, Ito H, Akazawa K, Kubota T, Kizu O, Yamada K, Nishimura T. Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features. J. Magn Reson Imag 2007; 25: 104-112.
11. Kuhl CK, Schild HH, Morakkabati N. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution. Radiology 2005; 236: 789-800.
12. Schnall MD, Blume J, Bluemke DA, DeAngelis GA, DeBruhl N, Harms S, Heywang-Köbrunner SH, Hylton N, Kuhl CK, Pisano ED, Causer P, Schnitt SJ, Thickman D, Stelling CB, Weatherall PT, Lehman C, Gatsonis CA. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 2006; 238: 42-53.
13. Kelcz F, Furman-Haran E, Grobgeld D, Degani H. Clinical testing of high-spatial-resolution parametric contrast-enhanced MR imaging of the breast. AJR Am J Roentgenol 2002; 179: 1485-92.
14. Furman-Haran E, Degani H. Parametric analysis of breast MRI. J. Comput Assist Tomogr 2002; 26: 376-86.
15. Hauth EA, Stockamp C, Maderwald S, Mühler A, Kimmig R, Jaeger H, Barkhausen J, Forsting M. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast- enhanced MR mammography. Clin Imaging 2006; 30: 160-5.
16. Li KL, Henry RG, Wilmes LJ, Gibbs J, Zhu X, Lu Y, Hylton NM. Kinetic assessment of breast tumors using high spatial resolution signal enhancement ratio (SER) imaging. Magn Reson Med 2007; 58: 572-81.
17. Vomweg TW, Teifke A, Kunz RP, Hintze C, Hlawatsch A, Kern A, Kreitner KF, Thelen M. Combination of low and high resolution sequences in two orientations for dynamic contrast-enhanced MRI of the breast: more than a compromise. Eur Radiol 2004; 14: 1732-42.
18. Uematsu T, Yuen S, Kasami M, Uchida Y. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?Breast Cancer Res Treat 2007; 103: 269-281.
19. Espinosa LA, Daniel BL, Vidarsson L, Zakhour M, Ikeda DM, Herfkens RJ. The lactating breast: contrast-enhanced MR imaging of normal tissue and cancer. Radiology 2005; 237: 429-436.
20. Huang W, Fisher PR, Dulaimy K, Tudorica LA, O'Hea B, Button TM. Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology 2004; 232: 585-591.
21. Pediconi F, Catalano C, Occhiato R, Venditti F, Fraioli F, Napoli A, Kirchin MA, Passariello R. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine. Radiology 2005; 237: 45-56.
22. Sardanelli F, Iozzelli A, Fausto A, Carriero A, Kirchin MA. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity. Radiology 2005; 235: 791-797.
23. Pediconi F, Catalano C, Roselli A, Padula S, Altomari F, Moriconi E, Pronio AM, Kirchin MA, Passariello R. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions. Radiology 2007; 243: 670-680.
24. Knopp MV, Bourne MW, Sardanelli F, Wasser MN, Bonomo L, Boetes C, Muller-Schimpfle M, Hall-Craggs MA, Hamm B, Orlacchio A, Bartolozzi C, Kessler M, Fischer U, Schneider G, Oudkerk M, Teh WL, Gehl HB, Salerio I, Pirovano G, La Noce A, Kirchin MA, Spinazzi A. Gadobenate dimeglumine- enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine. AJR Am J Roentgenol 2003; 181: 663-676.
25. Desmond KL, Ramsay EA, Plewes DB. Comparison of biphasic and reordered fat suppression for dynamic breast MRI. J. Magn Reson Imaging 2007; 25: 1293-1298.
26. Flask CA, Salem KA, Moriguchi H, Lewin JS, Wilson DL, Duerk JL. Keyhole Dixon method for faster, perceptually equivalent fat suppression. J. Magn Reson Imaging 2003; 18: 103-112.
27. Morrell GR. Rapid fat suppression in MRI of the breast with short binomial pulses. J. Magn Reson Imaging 2006; 24: 1172-6.
28. Peng Q, McColl RW, Wang J, Weatherall PT. Novel rapid fat suppression strategy with spectrally selective pulses. Magn Reson Med 2005; 54: 1569-74.
29. Ma J, Vu AT, Son JB, Choi H, Hazle JD. Fat-suppressed three-dimensional dual echo Dixon technique for contrast agent enhanced MRI. J. Magn Reson Imaging 2006; 23: 36-41.
30. Yu H, Reeder SB, McKenzie CA, Brau AC, Shimakawa A, Brittain JH, Pelc NJ. Single acquisition water-fat separation: feasibility study for dynamic imaging. Magn Reson Med 2006; 55: 413-422.
31. Reeder SB, McKenzie CA, Pineda AR, Yu H, Shimakawa A, Brau AC, Hargreaves BA, Gold GE, Brittain JH. Water-fat separation with IDEAL gradient-echo imaging. J. Magn Reson Imaging 2007; 25: 644-652.
32. Fan X, Abe H, Medved M, Foxley S, Arkani S, Zamora MA, Olopade OI, Newstead GM, Karczmar GS. Fat suppression with spectrally selective inversion vs. high spectral and spatial resolution MRI of breast lesions: qualitative and quantitative comparisons. J. Magn Reson Imaging 2006; 24: 1311-1315.
33. Klifa CS, Shimakawa A, Siraj Z, Gibbs JE, Wilmes LJ, Partridge SC, Proctor E, Hylton NM. Characterization of breast lesions using the 3D FIESTA sequence and contrast-enhanced magnetic resonance imaging. J. Magn Reson Imaging 2007; 25: 82-88.
34. Dougherty L, Isaac G, Rosen MA, Nunes LW, Moate PJ, Boston RC, Schnall MD, Song HK. High frame-rate simultaneous bilateral breast DCE-MRI. Magn Reson Med 2007; 57: 220-225.
35. Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J. Magn Reson Imaging 1999; 10: 254-259.
36. Moate PJ, Dougherty L, Schnall MD, Landis RJ, Boston RC. A modified logistic model to describe gadolinium kinetics in breast tumors. Magn Reson Imaging 2004; 22: 467-473.
37. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 1989; 170: 681-686.
38. Buadu LD, Murakami J, Murayama S, Hashiguchi N, Sakai S, Masuda K, Toyoshima S, Kuroki S, Ohno S. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996; 200: 639-649.
39. Szabo BK, Aspelin P, Wiberg MK, Bone B. Dynamic MR imaging of the breast. Analysis of kinetic and morphologic diagnostic criteria. Acta Radiol 2003; 44: 379-386.
40. Ikeda O, Yamashita Y, Morishita S, Kido T, Kitajima M, Okamura K, et al. Characterization of breast masses by dynamic enhanced MR imaging. A. logistic regression analysis. Acta Radiol 1999; 40: 585-592.
41. Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?Radiology 1999; 211: 101-110.
42. Fan X, Medved M, Karczmar GS, Yang C, Foxley S, Arkani S, Recant W, Zamora MA, Abe H, Newstead GM. Diagnosis of suspicious breast lesions using an empirical mathematical model for dynamic contrast-enhanced MRI. Magn Reson Imaging 2007; 25: 593-603.
43. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM. Estimating kinetic parameters from dynamic contrastenhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J. Magn Reson Imaging 1999; 10: 223-232.
44. Li X, Huang W, Yankeelov TE, Tudorica A, Rooney WD, Springer CSJ. Shutter-speed analysis of contrast reagent bolus-tracking data: preliminary observations in benign and malignant breast disease. Magn Reson Med 2005; 53: 724-729.
45. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J. Magn Reson Imaging 1997; 7: 91-101.
46. Griebel J, Mayr NA, de Vries A, Knopp MV, Gneiting T, Kremser C, Essig M, Hawighorst H, Lukas PH, Yuh WT. Assessment of tumor microcirculation: a new role of dynamic contrast MR imaging. J. Magn Reson Imaging 1997; 7: 111-119.
47. Buckley DL, Drew PJ, Mussurakis S, Monson JRT, Horsman A. Microvessel density in invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. J. Magn Reson Imaging 1997; 7: 461-464.
48. Vincensini D, Dedieu V, Renou JP, Otal P, Joffre F. Measurement of extracellular volume fraction and capillary permeability in tissues using dynamic spin-lattice relaxometry: studies in rabbit muscles. Magn Reson Imaging 2003; 21: 85-93.
49. Vincensini D, Dedieu V, Eliat PA, Vincent P, Bailly C, de Certaines J, Joffre F. Magnetic resonance imaging measurements of vascular permeability and extracellular volume fraction of breast tumors by dynamic Gd-DTPA-enhanced relaxometry. Magn Reson Imaging 2007; 25: 293-302.
50. Yankeelov TE, Luci JJ, Lepage M, Li R, Debusk L, Lin PC, Price RR, Gore JC. Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. Magn Reson Imaging 2005; 23: 519-529.
51. Yankeelov TE, Lepage M, Chakravarthy A, Broome EE, Niermann KJ, Kelley MC, Meszoely I, Mayer IA, Herman CR, McManus K, Price RR, Gore JC. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 2007; 25: 1-13.
52. Pickles MD, Lowry M, Manton DJ, Gibbs P, Turnbull LW. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005; 91: 1-10.
53. Martincich L, Montemurro F, De Rosa G, Marra V, Ponzone R, Cirillo S, Gatti M, Biglia N, Sarotto I, Sismondi P, Regge D, Aglietta M. Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 2004; 83: 67-76.
54. Delille JP, Slanetz PJ, Yeh ED, Halpern EF, Kopans DB, Garrido L. Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study. Radiology 2003; 228: 63-69.
55. Garimella V, Qutob O, Fox JN, Long ED, Chaturvedi A, Turnbull LW, Drew PJ. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients. Eur J Surg Oncol 2007; 33: 157-161.
56. Kwong MS, Chung GG, Horvath LJ, Ward BA, Hsu AD, Carter D, Tavassoli F, Haffty B, Burtness BA. Postchemotherapy MRI overestimates residual disease compared with histopathology in responders to neoadjuvant therapy for locally advanced breast cancer. Cancer J 2006; 12: 212-221.
57. Denis F, Desbiez-Bourcier AV, Chapiron C, Arbion F, Body G, Brunereau L. Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer. Eur J Surg Oncol 2004; 30: 1069-76.
58. Cheung YC, Chen SC, Su MY, See LC, Hsueh S, Chang HK, Lin YC, Tsai CS. Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI. Breast Cancer Res Treat 2003; 78: 51-58.
59. Yu HJ, Chen JH, Mehta RS, Nalcioglu O, Su MY. MRI Measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy. J. Magn Reson Imaging 2007; 26: 615-623.
60. Abramson RG, Mavi A, Cermik T, Basu S,Wehrli NE, Houseni M, Mishra S, Udupa J, Lakhani P, Maidment ADA, Torigian DA, Alavi A. Age-related structural and functional changes in the breast: multimodality correlation with digital mammography, computed tomography, magnetic resonance imaging, and positron emission tomography. Semin Nucl Med 2007; 37: 146-153.
61. Müller-Schimpfle M, Ohmenhaüser K, Stoll P, Dietz K, Claussen CD. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 1997; 203: 145-149.
62. Sinha S, Lucas-Quesada FA, Sinha U, DeBruhl N, Bassett LW. In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J. Magn Reson Imaging 2002; 15: 693-704.
63. Marini C, Iacconi C, Giannelli M, Cilotti A, Moretti M, Bartolozzi C. Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol. 2007; 17: 246-255 (Epub ahead of print).
64. Rubesova E, Grell AS, De Maertelaer V, Metens T, Chao SL, Lemort M. Quantitative diffusion imaging in breast cancer: a clinical prospective study. J. Magn Reson Imaging 2006; 24: 319-324.
65. Woodhams R, Matsunaga K, Iwabuchi K, Kan S, Hata H, Kuranami M, Watanabe M, Hayakawa K. Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J. Comput Assist Tomogr 2005; 29: 644-649.
66. Woodhams R, Matsunaga K, Kan S, Hata H, Ozaki M, Iwabuchi K, Kuranami M,Watanabe M, Hayakawa K. ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 2005; 4: 35-42.
67. Guo Y, Cai YQ, Cai ZL, Gao YG, An NY, Ma L, Mahankali S, Gao JH. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J. Magn Reson Imaging 2002; 16: 172-178.
68. Yabuuchi H, Soeda H, Matsuo Y, Okafuji T, Eguchi T, Sakai S, Kuroki S, Tokunaga E, Ohno S, Nishiyama K, Hatakenaka M, Honda H. Phyllodes tumor of the breast: correlation between MR findings and histologic grade. Radiology 2006; 241: 702-709.
69. Kuroki Y, Nasu K, Kuroki S, Murakami K, Hayashi T, Sekiguchi R, Nawano S. Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value. Magn Reson Med Sci 2004; 15: 79-85.
70. Kinoshita T, Yashiro N, Ihara N, Funatu H, Fukuma E, Narita M. Diffusion-weighted half-Fourier single-shot turbo spin echo imaging in breast tumors: differentiation of invasive ductal carcinoma from fibroadenoma. J. Comput Assist Tomogr 2002; 26: 1042-1046.
71. Geschwind JF, Artemov D, Abraham S, Omdal D, Huncharek MS, McGee C, Arepally A, Lambert D, Venbrux AC, Lund GB. Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J. Vasc Interv Radiol 2000; 11: 1245-1255.
72. Stegman LD, Rehemtulla A, Hamstra DA, Rice DJ, Jonas SJ, Stout KL, Chenevert TL, Ross BD. Diffusion MRI detects events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy. Gene Ther 2000; 7: 1005-1010.
73. Theilmann RJ, Borders R, Trouard TP, Xia G, Outwater E, Ranger-Moore J, Gillies RJ, Stopeck A. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 2004; 6: 831-837.
74. Lee KC, Moffat BA, Schott AF, Layman R, Ellingworth S, Juliar R, Khan AP, Helvie M, Meyer CR, Chenevert TL, Rehemtulla A, Ross BD. Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy. Clin Cancer Res 2007; 13: 443-450.
75. Pickles MD, Gibbs P, Lowry M, Turnbull LW. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 2006; 24: 843-847.
76. Bolan PJ, Nelson MT, Yee D, Garwood M. Imaging in breast cancer: magnetic resonance spectroscopy. Breast Cancer Res 2005; 7: 149-152.
77. Yeung DK, Yang WT, Tse GM. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. Radiology 2002; 225: 190-197.
78. Bartella L, Morris EA, Dershaw DD, Liberman L, Thakur SB, Moskowitz C, Guido J, Huang W. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology 2006; 239: 686-692.
79. 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T. Radiology 2005; 236: 465-475.
80. Katz-Brull R, Lavin PT, Lenkinski RE. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J. Natl Cancer Inst 2002; 94: 1197-1203.
81. Tse GM, Cheung HS, Pang LM, Chu WC, Law BK, Kung FY, Yeung DK. Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors. AJR Am J Roentgenol 2003; 181: 1267-1272.
82. 1H MR spectroscopy. Magn Reson Med 2003; 50: 1134-1143.
83. Jacobs MA, Barker PB, Bottomley PA, Bhujwalla Z, Bluemke DA. Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J. Magn Reson Imaging 2004; 19: 68-75.
84. 1H MRS at 1.5 T. Eur Radiol 2005; 15: 1037-1043.
85. 1H MR spectroscopy using water as an internal reference at 1.5 T. MAGMA 2006; 19: 96-104.
86. Jagannathan NR, Kumar M, Seenu V, Coshic O, Dwivedi SN, Julka PK, Srivastava A, Rath GK. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001; 84: 1016-1022.
87. Meisamy S, Bolan PJ, Baker EH, Bliss RL, Gulbahce E, Everson LI, Nelson MT, Emory TH, Tuttle TM, Yee D, Garwood M. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy: a pilot study at 4 T. Radiology 2004; 233: 424-431.
88. Kumar M, Jagannathan NR, Seenu V, Dwivedi SN, Julka PK, Rath GK. Monitoring the therapeutic response of locally advanced breast cancer patients: sequential in vivo proton MR spectroscopy study. J. Magn Reson Imaging 2006; 24: 325-332.
89. Thomas MA, Wyckoff N, Yue K, Binesh N, Banakar S, Chung HK, Sayre J, DeBruhl N. Two-dimensional MR spectroscopic characterization of breast cancer in vivo. Technol Cancer Res Treat 2005; 4: 99-106.
90. Thomas MA, Binesh N, Yue K, DeBruhl N. Volume-localized two-dimensional correlated magnetic resonance spectroscopy of human breast cancer. J. Magn Reson Imaging 2001; 14: 181-186.
91. Barbier EL, Lamalle L, Decorps M. Methodology of brain perfusion imaging. J. Magn Reson Imaging 2001; 13: 496-520.
92. Zhu DC, Buonocore MH. Breast tissue differentiation using arterial spin tagging. Magn Reson Med 2003; 50: 966-975.
93. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility weighted echo-planar perfusion MR imaging. Radiology 2002; 223: 11-29.
94. Phillip H, Kuo MD, PhD Emanuel Kanal MD, Ali K, Abu-Alfa MD, Shawn E. Cowper, MD Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis1. Radiology 2007; 242: 647-649.
95. Kuhl CK, Bieling H, Gieseke J, Ebel T, Mielcarek P, Far F, Folkers P, Elevelt A, Schild HH. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging. Radiology 1997; 202: 87-95.
96. Kvistad KA, Rydland J, Vainio J, Smethurst HB, Lundgren S, Fjosne HE, Haraldseth O. Breast lesions: evaluation with dynamic contrast enhanced TI-weighted MR imaging and with T2*-weighted first-pass perfusion imaging. Radiology 2000; 216: 545-553.
97. Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Garrido L. Breast cancer: regional blood flow and blood volume measured with magnetic susceptibility-based MR imaging-initial results. Radiology 2002; 223: 558-565.
98. Tozaki M, Fukuda K, Suzuki M. Dynamic high-spatial-resolution MR imaging of invasive ductal carcinoma: influence of histological scirrhous component on MR descriptors. Magn Reson Med Sci 2006; 5: 137-146.
99. Torheim G, Godtliebsen F, Axelson D, Kvistad KA, Haraldseth O, Rinck PA. Feature extraction and classification of dynamic contrast-enhanced T2*-weighted breast image data. IEEE Trans Med Imaging 2001; 20: 1293-1301.
100. Makkat S, Luypaert R, Sourbron S, Stadnik T, De Mey J. Quantification of perfusion and permeability in breast tumors with a deconvolution-based analysis of second-bolus T1-DCE data. J. Magn Reson Imaging 2007; 25: 1159-1167.
101. Manduca A, Oliphant TE, Dresner MA, Mahowald JL, Kruse SA, Amromin E, Felmlee JP, Greenleaf JF, Ehman RL. Magnetic resonance elastography: non-invasive mapping of tissue elasticity. Med Image Anal 2001; 5: 237-254.
102. Lorenzen J, Sinkus R, Lorenzen M, Dargatz M, Leussler C, Röschmann P, Adam G. MR elastography of the breast:preliminary clinical results. Rofo 2002; 174: 830-4.
103. Xydeas T, Siegmann K, Sinkus R, Krainick-Strobel U, Miller S, Claussen CD. Magnetic resonance elastography of the breast: correlation of signal intensity data with viscoelastic properties. Invest Radiol 2005; 40: 412-20.
104. Lorenzen J, Sinkus R, Biesterfeldt M, Adam G. Menstrual-cycle dependence of breast parenchyma elasticity: estimation with magnetic resonance elastography of breast tissue during the menstrual cycle. Invest Radiol 2003; 38: 236-240.
105. Sinkus R, et al. High-resolution tensor MR elastography for breast tumour detection. Phys Med Biol 2000; 45: 1649-1664.
106. Sinkus R, Tanter M, Catheline S, Lorenzen J, Kuhl C, Sondermann E, Fink M. Imaging anisotropic and viscous properties of breast tissue by magnetic resonance-elastography. Magn Reson Med 2005; 53: 372-387.
107. Wiener JI, Schilling KJ, Adami C, Obuchowski NA. Assessment of suspected breast cancer by MRI: a prospective clinical trial using a kinetic and morphologic analysis. AJR Am J Roentgenol 2005; 184: 878-886.
108. Behrens S, Laue H, Althaus M, Boehler T, Kuemmerlen B, Hahn HK, Peitgen HO. Computer assistance for MR based diagnosis of breast cancer: Present and future challenges. Comput Med Imaging Graph 2007; 31: 236-247.
109. Nunes LW, Schnall MD, Orel SG. Update of breast MR imaging architectural interpretation model. Radiology 2001; 219: 484-494.
110. Sinha S, Lucas-Quesada FA, DeBruhl ND, Sayre J, Farria D, Gorczyca DP, Bassett LW. Multifeature analysis of Gd-enhanced MR images of breast lesions. J. Magn Reson Imaging 1997; 7: 1016-1026.
111. Chen W, Giger ML, Lan L, Bick U. Computerized interpretation of breast MRI: investigation of enhancement-variance dynamics. Med Phys 2004; 31: 1076-1082.
112. Gilhuijs KG, Deurloo EE, Muller SH, Peterse JL, Kool LJS. Breast MR imaging in women at increased lifetime risk of breast cancer: clinical system for computerized assessment of breast lesions initial results. Radiology 2002; 225: 907-916.
113. Subramanian KR, Brockway JP, Carruthers WB. Interactive detection and visualization of breast lesions from dynamic contrast enhanced MRI volumes. Comput Med Imaging Graph 2004; 28: 435-444.
114. Tanner C, Schnabel JA, Hill DL, Hawkes DJ, Degenhard A, Leach MO, Hose DR, Hall-Craggs MA, Usiskin SI. Quantitative evaluation of free-form deformation registration for dynamic contrast-enhanced MR mammography. Med Phys 2007; 34: 1221-1233.
115. Chen W, Giger ML, Bick U. A fuzzy c-means (FCM)-based approach for computerized segmentation of breast lesions in dynamic contrast-t-enhanced MR images. Acad Radiol 2006; 13: 63-72.
116. Coto E, Grimm S, Bruckner S, Groeller E, Kanitsarand A, Rodriguez O. MammoExplorer: an advanced CAD application for breast DCE-MRI. Proceedings of Vision, Modelling, and Visualization Conference, Erlangen, Germany, 2005; 91.
117. Lucht R, Delorme S, Brix G. Neural network-based segmentation of dynamic MR mammographic images. Magn Reson Imaging 2002; 20: 147-154.
118. Jacobs MA, Barker PB, Bluemke DA, Maranto C, Arnold C, Herskovits EH, Bhujwalla Z. Benign and malignant breast lesions: diagnosis with multiparametric MR imaging. Radiology 2003; 229: 225-232.
119. Woods BJ, Clymer BD, Kurc T, Heverhagen JT, Stevens R, Orsdemir A, Bulan O, Knopp MV. Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-t-enhanced magnetic resonance breast image data. J. Magn Reson Imaging 2007; 25: 495-501.
120. Stoutjesdijk MJ, Fuetterer JF, Boetes C, van Dieand LE, Jager G, Barentsz JO. Variability in the description of morphologic and contrast enhancement characteristics of breast lesions on magnetic resonance imaging. Invest Radiol 2005; 40: 355-362.
121. Liney GP, Sreenivas M, Gibbs P, Garcia-Alvarez R, Turnbull LW. Breast lesion analysis of shape technique: semiautomated vs. manual morphological description. J. Magn Reson Imaging 2006; 23: 493-498.
122. Chen W, Giger ML, Lan L, Bick U. Computerized interpretation of breast MRI: investigation of enhancement-variance dynamics. Med Phys 2004; 31: 1076-1082.
123. Rangayyan RM, El-Faramawy NM, Desautels JEL, Alim OA. Measures of acutance and shape for classification of breast tumors. IEEE Trans Med Imaging 1997; 16: 799-810.